003120.KS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 02:30):

Ilsung Pharmaceuticals Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, anti-coagulants, circulatory system drugs, contrast agents, diabetes treatments, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, anesthetics, antipyretics, and cardiovascular system products...

Stats
Today's Volume	9 214.00
Average Volume	20 872.00
Market Cap	134.61B
EPS	KRW0 ( 2023-09-30 )
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW10.87 (0.06%)

Volume Correlation

Long: -0.20 (neutral)

Short: 0.36 (neutral)

Signal:(38.962) Neutral

Ilsung Pharmaceuticals Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Ilsung Pharmaceuticals Correlation - Currency/Commodity

-0.04
( neutral )

-0.02
( neutral )

-0.45
( neutral )

0.24
( neutral )

0.34
( neutral )

0.14
( neutral )

Ilsung Pharmaceuticals Financials

Annual	2023
Revenue:	KRW78.05B
Gross Profit:	KRW34.72B (44.48 %)
EPS:	KRW-2 994.34

Q4	2023
Revenue:	KRW22.02B
Gross Profit:	KRW8.97B (40.75 %)
EPS:	KRW-5 825.42

Q3	2023
Revenue:	KRW18.07B
Gross Profit:	KRW7.52B (41.60 %)
EPS:	KRW657.53

Q2	2023
Revenue:	KRW20.03B
Gross Profit:	KRW10.79B (53.85 %)
EPS:	KRW-172.87

Financial Reports:

No articles found.

Ilsung Pharmaceuticals